Anchor Capital Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-58,235
Closed -$11K 317
2015
Q3
$11K Sell
58,235
-1,948
-3% -$663 ﹤0.01% 282
2015
Q2
$42K Hold
60,183
﹤0.01% 288
2015
Q1
$41K Hold
60,183
﹤0.01% 296
2014
Q4
$48K Sell
60,183
-370
-0.6% -$253 ﹤0.01% 308
2014
Q3
$28K Hold
60,553
﹤0.01% 325
2014
Q2
$30K Buy
60,553
+478
+0.8% +$231 ﹤0.01% 319
2014
Q1
$19K Sell
60,075
-2,570
-4% -$955 ﹤0.01% 309
2013
Q4
$21K Sell
62,645
-190
-0.3% -$230 ﹤0.01% 301
2013
Q3
$127K Hold
62,835
﹤0.01% 298
2013
Q2
$119K Buy
+62,835
New +$110K ﹤0.01% 289

Other funds holding GCVRZ

Anchor Capital Advisors's GCVRZ Position: Q4 2015 in Review

Anchor Capital Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 58,235 shares — an estimated $11K sold.

Anchor Capital Advisors first reported a position in GCVRZ in Q2 2013 and held it in 10 quarters. The position peaked at $127K in Q3 2013. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • Anchor Capital Advisors reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • Anchor Capital Advisors sold 58,235 Sanofi Contingent Value Rights shares in Q4 2015, an estimated $11K.
  • Anchor Capital Advisors first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 10 quarters.
  • Anchor Capital Advisors's Sanofi Contingent Value Rights position peaked at $127K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on Anchor Capital Advisors's 13F filing for Q4 2015, filed 4 Feb 2016.